Pages that link to "Item:Q5123180"
From MaRDI portal
The following pages link to Sample size re‐estimation in clinical trials (Q5123180):
Displaying 15 items.
- Most stable sample size determination in clinical trials (Q2324266) (← links)
- Sample size determination in clinical trials with multiple endpoints (Q2516980) (← links)
- A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity (Q2674509) (← links)
- Sample-Size Redetermination for Repeated Measures Studies (Q3078987) (← links)
- Sample Size Reestimation for Clinical Trials With Censored Survival Data (Q4468459) (← links)
- Adapting sample size calculations to repeated measurements in clinical trials (Q4540835) (← links)
- Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials (Q4962947) (← links)
- Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials (Q5115628) (← links)
- Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data (Q5135527) (← links)
- Semi-blinded design in clinical trials (Q6096185) (← links)
- A seamless phase II/III design with dose optimization for oncology drug development (Q6618336) (← links)
- Point estimation for adaptive trial designs. II: Practical considerations and guidance (Q6625791) (← links)
- Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends (Q6625972) (← links)
- Blinded sample size reestimation for negative binomial regression with baseline adjustment (Q6627398) (← links)
- Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths (Q6629406) (← links)
